Ascendiant Capital Markets Lowers PAVmed (NASDAQ:PAVM) Price Target to $19.00
PAVmed (NASDAQ:PAVM – Get Free Report) had its target price cut by analysts at Ascendiant Capital Markets from $19.50 to $19.00 in a report released on Friday,Benzinga reports. The firm presently has a “buy” rating on the stock. PAVmed Stock Up 0.0% PAVM opened at $0.63 on Friday. PAVmed has a twelve month low of […]
